Results 71 to 80 of about 728 (151)

P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer. [PDF]

open access: yesJ Pathol, 2022
Maynard JP   +13 more
europepmc   +1 more source

SYNTHESIS OF NEW FUSED BENZOPYRANO-BENZODIAZEPINONES

open access: yesHeterocyclic Communications, 2002
Raffle Gharbi   +3 more
openaire   +1 more source

Neuropharmacological screening of two 1,5-benzodiazepine compounds in mice [PDF]

open access: yes, 2010
Dorra Dridi   +5 more
core   +1 more source

A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6. [PDF]

open access: yesJ Med Chem, 2021
Shen Y   +26 more
europepmc   +1 more source

Harnessing unprotected deactivated amines and arylglyoxals in the Ugi reaction for the synthesis of fused complex nitrogen heterocycles. [PDF]

open access: yesBeilstein J Org Chem
Gómez-Ayuso J   +5 more
europepmc   +1 more source

Delta-like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview. [PDF]

open access: yesCancer Sci, 2021
Matsuo K   +7 more
europepmc   +1 more source

Biosynthesis of Circumdatins Employs an Anthranilate Tailoring Pathway for NRPS Substrate Supplies. [PDF]

open access: yesOrg Lett
Sato Y   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy